Clinical Trial

VIM+PTT MRgFUS for PD

Study acronym: Dual-TargetFUS
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this prospective, single-arm, open-label study is to assess the safety and efficacy of the staged, dual-target(VIM+PTT thalamotomy)to treat Patiensts with Parkinson Disease using transcranial magnetic resonance guided focused ultrasound system ExAblate 4000, InSightec Ltd.
Trial Details
NCT Number NCT07044973
Lead Sponsor Chinese PLA General Hospital
Conditions Parkinson Disease
Enrollment 20 participants
Start Date 2025-07-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-01